Literature DB >> 18214500

[Significance of clinically latent bacterial arthritis].

C Meyer-Scholten1, A Valeva, K Zorn, A Meurer, H G Fassbender.   

Abstract

The classical septic bacterial arthritis is a rare event, but can be distinguished by unequivocal signs such as fibrin exudation and neutrophilic masses (pus). For a long time we have been observing an abortive form of bacterial arthritis in biopsies which subsides spontaneously without antibiotic intervention. Only very early during the course can Staphyolcoccus aureus or epidermidis be detected. Despite the brief presence of bacteria, enzymes from the neutrophils can destroy cartilage and bone. The fact that the attending physician had suspected a bacterial infection in only 7% of these patients highlights the diagnostic complexity. We have termed this form clinically latent bacterial arthritis (CLBA). Structural changes in the synovial membrane, e.g. in rheumatoid arthritis or osteoarthritis, predispose for a hematogenous seeding of endogenous staphylococci and trigger clinically unapparent, temporary infections. This clinically latent bacterial superinfection (CLSI) is also self-limiting, but the high degrading potential of the neutrophilic proteases makes CLSI a very probable contributing factor in joint destruction.

Entities:  

Mesh:

Year:  2008        PMID: 18214500     DOI: 10.1007/s00393-007-0251-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  15 in total

1.  MONOARTICULAR ARTHRITIS IN CHILDREN.

Authors:  E G BYWATERS; B M ANSELL
Journal:  Ann Rheum Dis       Date:  1965-03       Impact factor: 19.103

2.  [Usefulness of 16S rDNA polymerase-chain-reaction (PCR) in the intraoperative detection of infection in revision of failed arthroplasties].

Authors:  J Kordelle; H Hossain; U Stahl; I Schleicher; H Haas
Journal:  Z Orthop Ihre Grenzgeb       Date:  2004 Sep-Oct

3.  Poor predictive value of broad-range PCR for the detection of arthroplasty infection in 92 cases.

Authors:  Konstantinos Panousis; Peter Grigoris; Ian Butcher; Bardeep Rana; James H Reilly; David L Hamblen
Journal:  Acta Orthop       Date:  2005-06       Impact factor: 3.717

Review 4.  Diagnosis of periprosthetic infection.

Authors:  Thomas W Bauer; Javad Parvizi; Naomi Kobayashi; Viktor Krebs
Journal:  J Bone Joint Surg Am       Date:  2006-04       Impact factor: 5.284

5.  [Classification and microbiology of osteomyelitis].

Authors:  W Zimmerli; U Flückiger
Journal:  Orthopade       Date:  2004-03       Impact factor: 1.087

6.  Analysis of 525 samples to determine the usefulness of PCR amplification and sequencing of the 16S rRNA gene for diagnosis of bone and joint infections.

Authors:  Florence Fenollar; Véronique Roux; Andréas Stein; Michel Drancourt; Didier Raoult
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

7.  Prospective comparative study of patients with culture proven and high suspicion of adult onset septic arthritis.

Authors:  M N Gupta; R D Sturrock; M Field
Journal:  Ann Rheum Dis       Date:  2003-04       Impact factor: 19.103

8.  Septic arthritis in a patient with juvenile rheumatoid arthritis.

Authors:  Scott T Sauer; Eric Farrell; Evan Geller; Peter D Pizzutillo
Journal:  Clin Orthop Relat Res       Date:  2004-01       Impact factor: 4.176

9.  [Problems with expert opinion for the assessment of septic arthritis].

Authors:  C Neugebauer; R Graf
Journal:  Orthopade       Date:  2004-04       Impact factor: 1.087

10.  Identification of bacteria on the surface of clinically infected and non-infected prosthetic hip joints removed during revision arthroplasties by 16S rRNA gene sequencing and by microbiological culture.

Authors:  Kate E Dempsey; Marcello P Riggio; Alan Lennon; Victoria E Hannah; Gordon Ramage; David Allan; Jeremy Bagg
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  1 in total

Review 1.  [Value of histological work-up for synovial diseases].

Authors:  I Berger; L Morawietz; M Jakobs; V Krenn
Journal:  Orthopade       Date:  2009-06       Impact factor: 1.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.